Skip to content

My Pharmacy News

mypharmacynews.com

  • Health News
  • Medications
  • Health Problems
  • Beauty & Balance
  • Personal Health

Home ยป ALK-positive

04/12/2018

Alectinib provides longer symptom improvement than crizotinib in ALK-positive lung cancer

Alectinib provides longer symptom improvement than crizotinib in ALK-positive non-small-cell lung cancer (NSCLC), according to results from the ALEX trial

Continue reading »
Latest Posts
Combined antibiotics more effective against Lyme disease: Study
Early investment key to ending disadvantage, says New Zealand report
Study finds cilostazol is well tolerated but doesnt prevent cognitive decline
Health Problems
What are Drug-Induced Nail Disorders?
Current State of Clinical Diagnostics
Machine Learning for Targeted Disease Treatment
Recent Posts
  • Combined antibiotics more effective against Lyme disease: Study
  • Early investment key to ending disadvantage, says New Zealand report
  • Study finds cilostazol is well tolerated but doesnt prevent cognitive decline
  • Neoadjuvant chemotherapy may help some breast cancer patients skip regional nodal irradiation
  • Dr Michael Mosley shares turning down the thermostat could prevent silent killer
Copyright © 2023